Publication | Closed Access

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

Breast OncologyMedicineClinical TrialsBreast CancerPharmacotherapyCancer TreatmentOncologyRadiation OncologyHealth Sciences